Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Prepaid Assets: 2024-2025

Historic Prepaid Assets for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $35.1 million.

  • Kura Oncology's Prepaid Assets rose 344.27% to $35.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.1 million, marking a year-over-year increase of 344.27%. This contributed to the annual value of $15.4 million for FY2024, which is N/A change from last year.
  • Kura Oncology's Prepaid Assets amounted to $35.1 million in Q3 2025, which was up 41.53% from $24.8 million recorded in Q2 2025.
  • Kura Oncology's 5-year Prepaid Assets high stood at $35.1 million for Q3 2025, and its period low was $7.9 million during Q3 2024.
  • Over the past 2 years, Kura Oncology's median Prepaid Assets value was $15.4 million (recorded in 2024), while the average stood at $17.0 million.
  • Data for Kura Oncology's Prepaid Assets shows a peak YoY skyrocketed of 344.27% (in 2025) over the last 5 years.
  • Kura Oncology's Prepaid Assets (Quarterly) stood at $15.4 million in 2024, then spiked by 344.27% to $35.1 million in 2025.
  • Its last three reported values are $35.1 million in Q3 2025, $24.8 million for Q2 2025, and $17.3 million during Q1 2025.